Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors

Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors

Bibliographic Details
Main Authors: Qiuji Wu, Qian Chu, Hongyan Zhang, Bin Yang, Xudong He, Yahua Zhong, Xianglin Yuan, Melvin L.K. Chua, Conghua Xie
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Cancer Communications
Online Access:https://doi.org/10.1002/cac2.12077
id doaj-e7a9b397a6cd468fb170de205e67d134
record_format Article
spelling doaj-e7a9b397a6cd468fb170de205e67d1342020-11-25T03:42:23ZengWileyCancer Communications2523-35482020-08-0140837437910.1002/cac2.12077Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitorsQiuji Wu0Qian Chu1Hongyan Zhang2Bin Yang3Xudong He4Yahua Zhong5Xianglin Yuan6Melvin L.K. Chua7Conghua Xie8Department of Radiation and Medical Oncology Zhongnan Hospital of Wuhan University Wuhan Hubei 430071 P. R. ChinaDepartment of Oncology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430030 P. R. ChinaDepartment of Radiation and Medical Oncology Zhongnan Hospital of Wuhan University Wuhan Hubei 430071 P. R. ChinaDepartment of Medical Oncology Hubei Cancer Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430079 P. R. ChinaDepartment of Gastroenterology Dongfeng Hospital Hubei University of Medicine Shiyan Hubei 442000 P. R. ChinaDepartment of Radiation and Medical Oncology Zhongnan Hospital of Wuhan University Wuhan Hubei 430071 P. R. ChinaDepartment of Oncology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430030 P. R. ChinaDepartment of Radiation and Medical Oncology Zhongnan Hospital of Wuhan University Wuhan Hubei 430071 P. R. ChinaDepartment of Radiation and Medical Oncology Zhongnan Hospital of Wuhan University Wuhan Hubei 430071 P. R. Chinahttps://doi.org/10.1002/cac2.12077
collection DOAJ
language English
format Article
sources DOAJ
author Qiuji Wu
Qian Chu
Hongyan Zhang
Bin Yang
Xudong He
Yahua Zhong
Xianglin Yuan
Melvin L.K. Chua
Conghua Xie
spellingShingle Qiuji Wu
Qian Chu
Hongyan Zhang
Bin Yang
Xudong He
Yahua Zhong
Xianglin Yuan
Melvin L.K. Chua
Conghua Xie
Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
Cancer Communications
author_facet Qiuji Wu
Qian Chu
Hongyan Zhang
Bin Yang
Xudong He
Yahua Zhong
Xianglin Yuan
Melvin L.K. Chua
Conghua Xie
author_sort Qiuji Wu
title Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
title_short Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
title_full Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
title_fullStr Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
title_full_unstemmed Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
title_sort clinical outcomes of coronavirus disease 2019 (covid‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
publisher Wiley
series Cancer Communications
issn 2523-3548
publishDate 2020-08-01
url https://doi.org/10.1002/cac2.12077
work_keys_str_mv AT qiujiwu clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
AT qianchu clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
AT hongyanzhang clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
AT binyang clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
AT xudonghe clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
AT yahuazhong clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
AT xianglinyuan clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
AT melvinlkchua clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
AT conghuaxie clinicaloutcomesofcoronavirusdisease2019covid19incancerpatientswithpriorexposuretoimmunecheckpointinhibitors
_version_ 1724525418152722432

Similar Items